Tamara Fountain - 12 Mar 2025 Form 4 Insider Report for RxSight, Inc. (RXST)

Role
Director
Signature
/s/ Shelley Thunen, as Attorney-in-Fact
Issuer symbol
RXST
Transactions as of
12 Mar 2025
Net transactions value
-$180,002
Form type
4
Filing time
13 Mar 2025, 16:46:51 UTC
Previous filing
10 Jun 2024
Next filing
04 Jun 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXST Common Stock Sale $180,002 -7,000 -22% $25.71 24,793 12 Mar 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported were effected pursuant to a Rule 10b5-1 trading plan established on December 11, 2024 by the Reporting Person.
F2 Represents the weighted average share price of an aggregate total of 7,000 shares sold in the price range of $25.355 to $26.175 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Remarks:

Exhibit 24 - Power of Attorney